BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou XQ, Li YP, Dang SS. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World J Hepatol 2024; 16(2): 164-176 [PMID: 38495282 DOI: 10.4254/wjh.v16.i2.164]
URL: https://www.wjgnet.com/1007-9327/full/v16/i2/164.htm
Number Citing Articles
1
Howard D Lee, Li-Yun Yuan. Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?World Journal of Hepatology 2024; 16(5): 684-687 doi: 10.4254/wjh.v16.i5.684
2
Balaji Palanisamy, Abul Kalam Azad Mandal. Unlocking the potential: Receptor-mediated targeted drug delivery in cancer therapyPathology - Research and Practice 2025; 270: 155955 doi: 10.1016/j.prp.2025.155955
3
Amria M. Mousa, Mohamed Abdelraof, Amany A. Hassabo, Doaa A. Darwish, Mona M.A. Abdel-Mottaleb, Rasha M. Allam. Marine L-arginase encapsulated in poly (lactic-co-glycolic acid) nanoparticles: A novel anti-cancer strategy for effective hepatocellular carcinoma treatment in vitro and in vivoJournal of Drug Delivery Science and Technology 2025; 109: 106980 doi: 10.1016/j.jddst.2025.106980
4
Ayhan Bergal, Muberra Andac, Francesco Trotta. Cyclodextrin-based chemically modified pH-Responsive new kind of aldehyde-functionalized nanosponge nanoparticles for doxorubicin hydrochloride deliveryJournal of Drug Delivery Science and Technology 2025; 107: 106853 doi: 10.1016/j.jddst.2025.106853
5
Veena Vijayan, Janitha M. Unagolla, Dhruvisha Panchal, Judith Eloyi John, Siddharth S. Menon, Jyothi U. Menon. Biomimetic nanoparticles for targeted therapy of liver diseaseRSC Pharmaceutics 2025;  doi: 10.1039/D5PM00044K
6
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, Hashem O. Alsaab. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNACell Biochemistry and Biophysics 2024; 82(3): 1947 doi: 10.1007/s12013-024-01395-6